Jonathan Kerr

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Source: Invest in ME

Jonathan Richard Kerr, BSc, MBBCh, MD, PhD, FRCPath, is a British researcher who became interested in ME/CFS after studying the consequences of Parvovirus B19 infection and finding that some of those infected went on to develop CFS. He has worked for St. George’s University of London[1] and as an Associate professor in the School of Medicine and Health Sciences at Universidad del Rosario, Bogotá, Colombia.[2] He returned to the UK in 2018, and practiced at the Department of Microbiology, Norfolk & Norwich University Hospitals NHS Foundation Trust.[3] Dr Kerr died in April 2023.[4]

Notable studies[edit | edit source]

Talks and interviews[edit | edit source]

Invest in ME International ME Conference[edit | edit source]

Online presence[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. ↑ "UK Charity for Myalgic Encephalomyelitis Centre of Excellence for ME Blog". investinme.org. Retrieved August 3, 2019.
  2. ↑ http://www.urosario.edu.co/Profesores/Listado-de-profesores/K/Kerr-Jonathan-Ricardo/
  3. ↑ 3.0 3.1 Kerr, Jonathan R (July 17, 2019). "Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors". Journal of Clinical Pathology. 72 (10): 651–658. doi:10.1136/jclinpath-2019-205822. ISSN 0021-9746.
  4. ↑ "Invest in ME Research Group | Facebook". www.facebook.com. Retrieved April 20, 2023.
  5. ↑ Kerr, Jonathan R.; Barrett, Ann-Marie; Curran, MartinD.; Behan, Wilhelmina M.H.; Middleton, Derek; Behan, Peter O. (January 1997). "Parvovirus B19 and Chronic Fatigue Syndrome". Journal of Chronic Fatigue Syndrome. 3 (3): 101–107. doi:10.1300/J092v03n03_07. ISSN 1057-3321.
  6. ↑ Kerr, Jonathan R.; Bracewell, Janice; Laing, Ian; Mattey, Derek L.; Bernstein, Robert M.; Bruce, Ian N.; Tyrrell, David A.J. (March 2002). "Chronic fatigue syndrome and arthralgia following parvovirus B19 infection". The Journal of Rheumatology. 29 (3): 595–602. ISSN 0315-162X. PMID 11911112.
  7. ↑ Kaushik, N.; Fear, D.; Richards, S.C.M.; McDermott, C.R.; Nuwaysir, E.F.; Kellam, P.; Harrison, T.J.; Wilkinson, R.J.; Tyrrell, D.A.J.; Holgate, S.T.; Kerr, J.R. (August 1, 2005). "Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome". Journal of Clinical Pathology. 58 (8): 826–832. doi:10.1136/jcp.2005.025718. ISSN 0021-9746. PMC 1770875. PMID 16049284.
  8. ↑ Smith, J; Fritz, E L; Kerr, JR; Cleare, A J; Wessely, S; Mattey, D L (August 1, 2005). "Association of chronic fatigue syndrome with human leucocyte antigen class II alleles". Journal of Clinical Pathology. 58 (8): 860–863. doi:10.1136/jcp.2004.022681. ISSN 0021-9746. PMC 1770867. PMID 16049290.
  9. ↑ Kerr, J R; Christian, P; Hodgetts, A; Langford, P R; Devanur, L D; Petty, R; Burke, B; Sinclair, L I; Richards, S C M; Montgomery, J; McDermott, C R; Harrison, T J; Kellam, P; Nutt, D J; Holgate, S T; Collaborative Clinical Study Group (June 2, 2006). "Current research priorities in chronic fatigue syndrome/myalgic encephalomyelitis: disease mechanisms, a diagnostic test and specific treatments". Journal of Clinical Pathology. 60 (2): 113–116. doi:10.1136/jcp.2006.042374. ISSN 0021-9746.
  10. ↑ Kerr, Jonathan R; Petty, Robert; Burke, Beverley; Gough, John; Fear, David; Sinclair, Lindsey I; Mattey, Derek L; Richards, Selwyn C; Montgomery, Jane; Baldwin, Don A; Kellam, Paul; Harrison, Tim J; Griffin, George E; Main, Janice; Enlander, Derek; Nutt, David J; Holgate, Stephen T (April 15, 2008). "Gene Expression Subtypes in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis". The Journal of Infectious Diseases. 197 (8): 1171–1184. doi:10.1086/533453. PMID 18462164.
  11. ↑ Zhang, L.; Gough, J.; Christmas, D.; Mattey, D.L.; Richards, S.C.M.; Main, J.; Enlander, D.; Honeybourne, D.; Ayres, J.G.; Nutt, D.J.; Kerr, J.R. (February 1, 2010). "Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis". Journal of Clinical Pathology. 63 (2): 156–164. doi:10.1136/jcp.2009.072561. ISSN 0021-9746. PMC 2921262. PMID 19955554.
  12. ↑ Kerr, J.R.; Gough, J.; Richards, S.C.M.; Main, J.; Enlander, D.; McCreary, M.; Komaroff, A.L.; Chia, J.K. (April 1, 2010). "Antibody to parvovirus B19 nonstructural protein is associated with chronic arthralgia in patients with chronic fatigue syndrome/myalgic encephalomyelitis". Journal of General Virology. 91 (4): 893–897. doi:10.1099/vir.0.017590-0. ISSN 0022-1317.
  13. ↑ Shimosako, Nana; Kerr, Jonathan R. (2014), "Use of single-nucleotide polymorphisms (SNPs) to distinguish gene expression subtypes of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)", Journal of Clinical Pathology, 67 (12), doi:10.1136/jclinpath-2014-202597
  14. ↑ Petty, RobertD.; McCarthy, Nail E.; Le Dieu, Rifca; Kerr, Jonathan R. (2016), "MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME)", PLOS One, doi:10.1371/journal.pone.0150904, PMID 26967895
  15. ↑ Kerr, Jonathan R. (February 2019). "Epstein-Barr virus induced gene-2 upregulation identifies a particular subtype of Chronic Fatigue Syndrome / Myalgic Encephalomyelitis". Frontiers in Pediatrics. 7: 59. doi:10.3389/fped.2019.00059.
  16. ↑ "IIMEC1". Invest in ME Research. Retrieved February 17, 2020.
  17. ↑ "IIMEC2". Invest in ME Research. Retrieved February 18, 2020.
  18. ↑ "IIMEC3". Invest in ME Research. Retrieved February 17, 2020.
  19. ↑ "IIMEC4". Invest in ME Research. Retrieved February 17, 2020.
  20. ↑ "IIMEC5 International ME Conference 2010". Invest in ME Research. Retrieved February 17, 2020.
Retrieved from "https://me-pedia.org/w/index.php?title=Jonathan_Kerr&oldid=240656"